Literature DB >> 33849501

Continuity in palliative care - analysis of intersectoral palliative care based on routine data of a statutory health insurance.

Laura Rehner1, Kilson Moon2, Wolfgang Hoffmann2, Neeltje van den Berg2.   

Abstract

BACKGROUND: The goal of palliative care is to prevent and alleviate a suffering of incurable ill patients. A continuous intersectoral palliative care is important. The aim of this study is to analyse the continuity of palliative care, particularly the time gaps between hospital discharge and subsequent palliative care as well as the timing of the last palliative care before the patient's death.
METHODS: The analysis was based on claims data from a large statutory health insurance. Patients who received their first palliative care in 2015 were included. The course of palliative care was followed for 12 months. Time intervals between discharge from hospital and first subsequent palliative care as well as between last palliative care and death were analysed. The continuity in palliative care was defined as an interval of less than 14 days between palliative care. Data were analysed using descriptive statistics and Chi-Square.
RESULTS: In 2015, 4177 patients with first palliative care were identified in the catchment area of the statutory health insurance. After general inpatient palliative care, 415 patients were transferred to subsequent palliative care, of these 67.7% (n = 281) received subsequent care within 14 days. After a stay in a palliative care ward, 124 patients received subsequent palliative care, of these 75.0% (n = 93) within 14 days. Altogether, 147 discharges did not receive subsequent palliative care. During the 12-months follow-up period, 2866 (68.7%) patients died, of these 78.7% (n = 2256) received palliative care within the last 2 weeks of life. Of these, 1223 patients received general ambulatory palliative care, 631 patients received specialised ambulatory palliative care, 313 patients received their last palliative care at a hospital and 89 patients received it in a hospice.
CONCLUSIONS: The majority of the palliative care patients received continuous palliative care. However, there are some patients who did not receive continuous palliative care. After inpatient palliative care, each patient should receive a discharge management for a continuation of palliative care. Readmissions of patients after discharge from inpatients palliative care can be an indication for a lack of support in the ambulatory health care setting and for an insufficient discharge management. Palliative care training and possibilities for palliative care consultations by specialists should strengthen the GPs in palliative care.

Entities:  

Keywords:  Claims data; Continuity of patients care; Hospice; Intersectoral palliative care; Palliative care; Rural; Urban

Year:  2021        PMID: 33849501     DOI: 10.1186/s12904-021-00751-0

Source DB:  PubMed          Journal:  BMC Palliat Care        ISSN: 1472-684X            Impact factor:   3.234


  9 in total

1.  Mobile Health Technologies for Continuous Monitoring of Cancer Patients in Palliative Care Aiming to Predict Health Status Deterioration: A Feasibility Study.

Authors:  Matea Pavic; Vanessa Klaas; Gudrun Theile; Johannes Kraft; Gerhard Tröster; David Blum; Matthias Guckenberger
Journal:  J Palliat Med       Date:  2019-12-23       Impact factor: 2.947

2.  [Good Practice of Secondary Data Analysis (GPS): guidelines and recommendations].

Authors:  E Swart; H Gothe; S Geyer; J Jaunzeme; B Maier; T G Grobe; P Ihle
Journal:  Gesundheitswesen       Date:  2015-01-26

3.  Care trajectories and survival after discharge from specialized inpatient palliative care--results from an observational follow-up study.

Authors:  Franziska Kötzsch; Stephanie Stiel; Maria Heckel; Christoph Ostgathe; Carsten Klein
Journal:  Support Care Cancer       Date:  2014-08-22       Impact factor: 3.603

4.  Systematic review of barriers and enablers to the delivery of palliative care by primary care practitioners.

Authors:  Mariko L Carey; Alison C Zucca; Megan Ag Freund; Jamie Bryant; Anne Herrmann; Bernadette J Roberts
Journal:  Palliat Med       Date:  2019-10       Impact factor: 4.762

Review 5.  Hospital at home: home-based end-of-life care.

Authors:  Sasha Shepperd; Daniela C Gonçalves-Bradley; Sharon E Straus; Bee Wee
Journal:  Cochrane Database Syst Rev       Date:  2016-02-18

6.  Does inpatient palliative care consultation impact outcomes following hospital discharge? A narrative systematic review.

Authors:  Mary Scott; Nicole Shaver; Julie Lapenskie; Sarina R Isenberg; Stephanie Saunders; Amy T Hsu; Peter Tanuseputro
Journal:  Palliat Med       Date:  2019-10-04       Impact factor: 4.762

7.  Risk factors for potentially avoidable readmissions due to end-of-life care issues.

Authors:  Jacques Donzé; Stuart Lipsitz; Jeffrey L Schnipper
Journal:  J Hosp Med       Date:  2014-02-14       Impact factor: 2.960

8.  mHealth Technologies for Palliative Care Patients at the Interface of In-Patient to Outpatient Care: Protocol of Feasibility Study Aiming to Early Predict Deterioration of Patient's Health Status.

Authors:  Gudrun Theile; Vanessa Klaas; Gerhard Tröster; Matthias Guckenberger
Journal:  JMIR Res Protoc       Date:  2017-08-16

9.  Study protocol for a multi-methods study: SAVOIR - evaluation of specialized outpatient palliative care (SAPV) in Germany: outcomes, interactions, regional differences.

Authors:  Antje Freytag; Markus Krause; Anna Bauer; Bianka Ditscheid; Maximiliane Jansky; Sabine Krauss; Thomas Lehmann; Ursula Marschall; Friedemann Nauck; Werner Schneider; Kathleen Stichling; Horst Christian Vollmar; Ulrich Wedding; Winfried Meißner
Journal:  BMC Palliat Care       Date:  2019-01-26       Impact factor: 3.234

  9 in total
  1 in total

1.  Comparison of survival between patients receiving general outpatient palliative care and patients receiving other palliative care - analysis of data of a statutory health insurance data.

Authors:  Kilson Moon; Laura Rehner; Wolfgang Hoffmann; Neeltje van den Berg
Journal:  BMC Palliat Care       Date:  2022-05-26       Impact factor: 3.113

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.